Peripheral Neuropathy: Causes and Symptoms — a Complete Differential Overview

Diabetes is the single most common cause of peripheral neuropathy worldwide, accounting for a substantial share of all diagnosed cases. Risk rises with disease duration and glycemic control quality — from around ten percent in people with newly diagnosed type 2 diabetes to over half of patients who have had diabetes for more than a decade.

The mechanism of diabetic nerve damage is multifactorial — chronic hyperglycemia damages the small blood vessels supplying nerves (microangiopathy), disrupts lipid metabolism, and causes abnormalities in insulin signaling pathways, which together lead to progressive damage of nerve fibers. Since this mechanism and its prevention are a broad topic in themselves, we've dedicated a separate article to it — alpha-lipoic acid and diabetic neuropathy — discussing specific evidence on supportive supplementation in this context.

Vitamin B12 is essential for synthesizing the myelin sheath of nerve fibers, so its chronic deficiency leads to peripheral neuropathy with a clinical picture that can be difficult to distinguish from diabetic neuropathy — especially in patients with diabetes, in whom both mechanisms can coexist. Groups at particular risk of B12 deficiency include older adults (due to naturally declining absorption), those following a vegan or vegetarian diet without supplementation, people after bariatric surgery or stomach resection, those with pernicious anemia, and those taking certain medications long-term, including metformin or proton pump inhibitors.

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common and burdensome side effects of cancer treatment, particularly with platinum-based drugs (e.g., oxaliplatin, cisplatin), taxanes (e.g., paclitaxel), and vinca alkaloids (e.g., vincristine).

Besides chemotherapy, peripheral neuropathy can also be caused by long-term use of certain anti-tuberculosis drugs (isoniazid), certain antibiotics (e.g., fluoroquinolones, metronidazole at high doses or long-term), and certain antiretroviral medications. Drug-induced neuropathy diagnosis is usually linked to a temporal relationship with starting the medication in question, and, where clinically feasible, improves after stopping or reducing the dose — this decision is always made by the treating physician, weighing the risk of neuropathy against the benefits of treating the underlying condition.

Chronic, excessive alcohol consumption is one of the more common causes of peripheral neuropathy in developed countries, acting through a combination of direct toxicity of ethanol and its metabolites on peripheral nerves and accompanying nutritional deficiencies (especially thiamine, i.e., vitamin B1, and other B vitamins), typical of people with chronic alcohol dependence. Alcoholic neuropathy usually develops slowly, over years of regular, excessive consumption, and partially resolves after complete abstinence combined with correcting nutritional deficiencies, though the degree of improvement depends on the duration and severity of damage before stopping.

Other toxic causes include occupational exposure to heavy metals (lead, mercury, arsenic) and certain industrial solvents — rarer in clinical practice, but worth considering in an atypical neuropathy presentation in people working in industries where such exposure is plausible.

Despite a careful, multi-step diagnostic work-up including blood tests, neurological examination, and sometimes electrophysiological studies (electromyography and nerve conduction studies), a specific single cause cannot be identified in a significant proportion of patients — especially older adults with mild, slowly progressive sensory neuropathy. In such cases, the term chronic idiopathic axonal polyneuropathy (CIAP) is used — a diagnosis of exclusion, made only after reasonably ruling out the most common, potentially treatable causes.

This diagnosis can be a source of frustration for patients hoping for a definitive answer, but it doesn't mean there's no possibility of treatment — management then focuses on symptom relief (primarily neuropathic pain) and monitoring for a cause that wasn't apparent on initial work-up to emerge over time.

Peripheral neuropathy is a good example of why automatically attributing a symptom to the single most obvious cause can be a clinical mistake. Although diabetes remains the most common culprit, systematically ruling out B12 deficiency, toxic exposure, drug-related causes, and autoimmune conditions has real significance — some of these causes are fully reversible if identified early enough, before nerve damage becomes permanent.